Dental Care Clinics in Parsippany, NJ Accepting Medicare
25 Dental Care Clinics found. Showing 21 - 25
 Simple Smile Dental Care Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2200 Nj-10 Suite 105, Parsippany, NJ 07054 Phone: 973-370-5221 |
Nayanesh K. Shah, D.d.s., Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1081 Parsippany Blvd, Suite 100, Parsippany, NJ 07054 Phone: 973-299-6161 Fax: 973-299-1800 |
Caggiano Orthodontics Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 316 Parsippany Rd, Parsippany, NJ 07054 Phone: 973-887-8780 Fax: 973-887-9045 |
Amara Dental Of Parsippany, P.a. Dentist Medicare: Not Enrolled in Medicare Practice Location: 39 Littleton Rd, Parsippany, NJ 07054 Phone: 973-334-3811 |
Prosthodent P.c. Dentist - Prosthodontics Medicare: Not Enrolled in Medicare Practice Location: 60 Baldwin Rd Ste 104, Parsippany, NJ 07054 Phone: 973-263-3006 Fax: 973-299-3990 |
News Archive
Highlights from the most recent issue of Epilepsy Currents
The latest issue of Epilepsy Currents is now available featuring expert commentary on abstracts in basic science and clinical topics.
The new health law is 'pro-business,' Obama says
The Christian Science Monitor: During President Barack Obama's speech in Maine Thursday, he focused some of his comments on how small businesses fare under the new health law. "'This healthcare tax is pro-jobs, it's pro-business, and it starts this year,' Mr. Obama said. ... The nonpartisan Congressional Budget Office estimates that tax credits to cover healthcare premiums would save small businesses $40 billion by 2019. But it's not clear that small-business owners are buying the argument.
Study examines effectiveness of mobile phone-based intervention to slow weight regain
A scalable, mobile phone-based intervention designed to slow weight regain after an initial weight loss had no significant effect on participants' weight, according to a study published this week in PLOS Medicine by Falko Sniehotta from Newcastle University, UK and colleagues.
ChromaDex records revenue of $5.78M for 2009
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the Fiscal Year ending January 2, 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.03 per share for the one year period ended January 2, 2010. As of January 2, 2010, cash, cash equivalents, and marketable securities totaled $471,378.
Time for no-fault vaccination compensation
David Isaacs, Professor of Pediatric Infectious Diseases at the University of Sydney, has called for the introduction of compensation for those who suffer a serious adverse reaction to vaccination.
› Verified 2 days ago
- 1
- 2(current)